Home » Healthcare » Pharmaceuticals » Naloxone Market

Naloxone Market By Route of Administration (Injectables, Nasal, Oral) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)By Extraction Process (Solvent-Extracted, Cold-Pressed) By Sa By Formulation (Parenteral, Intranasal, Sublingual), By Dosage (4mg/0.1 ml, 2mg/0.1 ml, 0.4 mg/0.4 ml, 2mg/0.4 ml, Others), By Sales Channel (Hospitals Pharmacy, Outpatient Retail Pharmacy, Online Pharmacy, Wholesaler) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Summary
Table Of Content

What is the Regulatory followed by Naloxone?

In 2019, the Therapeutic Goods Administration (TGA) classified Naloxone as Schedule 3 when used to treat opioid overdoses, allowing it to be purchased over-the-counter (OTC) in Australia. In addition, because of the high rate of opioid overdose in this region, many European countries allow take-home naloxone. Take-home naloxone programs are available in seven European countries: Spain, Denmark, Germany, Italy, Norway, Estonia, and the United Kingdom.

What is the Market Size of Naloxone in terms of value?

Global Naloxone Market is predicted to rise at a substantial CAGR of 5.3 percent in the future years. The global market for Naloxone was estimated to be worth USD 3415.2 million in 2021 and is anticipated to grow to USD 5887.09 million by 2028. The leading market participants anticipate that the demand for Naloxone will rise significantly over the next few years, creating revenue opportunities totaling USD 2471.89 million between 2022 and 2028.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What is the Recent Development for Naloxone?

Government and non-governmental organizations in developed and developing countries are launching awareness campaigns to educate people about Naloxone overdose and treatment options. For example, in the United States’s 40 states, Good Samaritan laws protect people who report overdoses in good faith. In addition, the range of offenses is protected by immunity provisions that vary by state. According to Regulatory Affairs Professional Society data, Naloxone is still not approved as an over-the-counter (OTC) drug by the US FDA. However, some organizations, such as Walgreens pharmacies, make naloxone products available over-the-counter in over 5,800 of its 8,200 locations to increase naloxone access.

Interesting Facts about Naloxone Industry

The top 5 countries for Naloxone exports are The U.S., The U.K, Germany, France, and Canada.
The top 5 importers of Naloxone are Mexico, India, Brazil, Russia, and Japan.
Rising Awareness of Opioid Overdose and Effective Treatment in Developed and Developing Countries and others are the major factors driving market growth.
The market is expected to be hindered by the negative effects of using Naloxone Spray, and others are projected to restrain the growth of the Naloxone market over the forecast period.
North America region had a major share in terms of volume and value in the global Naloxone market in 2021.
Nasal Naloxone to witness high growth during the forecast period.

Who are the Top 10 companies in Naloxone market in terms of value?

The key players in the global Naloxone market include SG Pharma Pvt. Ltd., ADAPT Pharma, Inc., Kaleo, Inc., Pfizer Inc., Amphastar Pharmaceuticals, Inc., Sandoz, Troikaa Pharmaceuticals Ltd., Samarth Life Sciences Pvt. Ltd., Somerset Therapeutics LLC. To increase their Naloxone production and capture a competitive market share on a global scale, these main companies are concentrating on new product development as well as technological innovation. In addition, certain regional and national players are making significant investments to diversify their product lines and boost sales. For instance, in November 2021, Hikma Pharmaceuticals PLC (Hikma), a pharmaceutical company, donated 50,000 vials of Naloxone Injection.

Who are the Top 10 Countries in the Naloxone Market?

The major countries in the global Naloxone market are China, India, the U.S., Canada, the U.K., Germany, France, Russia, Japan, and Mexico. In 2021, the United States will dominate the global market for Naloxone both as a manufacturer and consumer. Additionally, the market in industrialized nations is being pushed primarily by rising consumer health consciousness and increased demand for organic Naloxone. For instance, the 40 states in the United States have Good Samaritan statutes that protect those who report overdoses in good faith. In addition, the range of offenses is shielded by immunity clauses that vary by state.

Which is the Key Route of Administration in the Naloxone Market?

The key Distribution Channels of Naloxone include injectable, nasal, and oral. Naloxone Spray is used to reverse the effects of opioid medications temporarily. The most popular route of administration for all products is a nasal spray. People who have never used opioid narcotics are not affected by the medication in this nasal spray. After the initial nasal spray dose is administered, the patient needs to see a doctor immediately. The Centers for Disease Control and Prevention estimate that 400,000 individuals would die from an opioid overdose between 1999 and 2021. Additionally, around 130 individuals every day in the United States pass away from opioid overdoses, which include illegal drugs like heroin or medications sold as heroin, as well as prescription drugs like oxycodone, fentanyl, morphine, and hydrocodone.

What are the Major Driving Factors for Naloxone Market?

Increased Awareness of Opioid Overdose and Effective Treatment in Developed and Developing Nations The Penington Institute estimates that drugs are responsible for 0.19 million premature deaths annually, with opioids being the primary cause of these deaths and largely preventable. In January 2020, the Centers for Disease Control and Prevention (CDC) predicted that 64,070 persons would have died from overdoses between 2019 and 2020. These figures thus provide a clear picture of the effects of opioid overdose on a worldwide scale. The increased frequency of opioid drug usage in both developed and developing nations is another element fueling market expansion. This trend is anticipated to boost demand for Naloxone. Globally, the use of opioids for managing chronic pain is rising, and as a result, non-medical opioid usage is rising. This is anticipated to fuel the expansion of the naloxone market.

What are the Major Restraints for Naloxone Market?

The use of Naloxone Spray has some negative effects that are expected to impede the market, which is the main restraint of the global Naloxone market and is projected to hinder market expansion. Some of the symptoms include body aches, sneezing, fever, perspiration, runny nose, yawning, goose bumps, weakness, anxiety, restlessness or irritability, diarrhea, shaking or trembling, nausea or vomiting, stomach cramps, a rapid heartbeat, and elevated blood pressure. Therefore, this drug should be given immediately if an opioid overdose is suspected or confirmed. This will assist in avoiding severe respiratory issues and excessive tiredness, which might cause death.

Which Region Dominated the World Naloxone Market?

Due to the presence of pharmaceutical behemoths, a sizable manufacturing base, and a supportive government commitment to tackle the region’s opioid overdose issue, North America owned the highest share of the worldwide naloxone market in 2021. The United States is the world’s largest market for Naloxone due to the dramatic rise in the use of prescription medicines, which has led to over 10 million high-risk opioid users in the country. Unfortunately, only 16 percent of this demographic, who make up an estimated 50 percent, are receiving therapy. The naloxone market has been stimulated by rising government initiatives to raise awareness of opioid addiction and its dangers. In addition, the Affordable Care Act’s effective reimbursement system and reduced drug costs have led to a rise in naloxone demand.

Due to a surge in opioid dependence, better awareness, and improved access to treatment, Europe has the highest growth. Europe is anticipated to be the second most lucrative naloxone market due to growing knowledge of the therapy for opioid overdose. Because Naloxone is being used more frequently for opioid overdose management in the region, the naloxone market in Latin America is anticipated to rise steadily.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Asia-Pacific is a developing market in the worldwide naloxone market due to greater availability and local manufacturers. Due to the poor market penetration of the product in these regions, the Middle East and Africa are the least profitable areas. Naloxone availability expanding globally and growing awareness of opioid overdose are anticipated to be important market drivers.

Segmentation of Global Naloxone Market-

Global Naloxone Market – By Route of Administration

Injectables
Nasal
Oral

Global Naloxone Market – By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Naloxone Market – By Extraction Process

Solvent-Extracted
Cold-Pressed

Global Naloxone Market – By Sales Channel

Direct Sales
Hypermarkets/Supermarkets
Convenience Stores
Specialty Retail Stores
Traditional Grocery Stores
Online Retailers

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Naloxone Market

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Naloxone Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Major Industry Challenges
3.2.3. Key Growth Pockets
3.3. Attractive Investment Proposition,2021
3.3.1. Route of Administration
3.3.2. Distribution Channel
3.3.3. Extraction Process
3.3.4. Sales Channel
3.3.5. Geography
3.4. Porter’s Five Forces Analysis
3.4.1. Threat of New Entrants
3.4.2. Bargaining Power of Buyers/Consumers
3.4.3. Bargaining Power of Suppliers
3.4.4. Threat of Substitute Route of Administrations
3.4.5. Intensity of Competitive Rivalry
3.5. Value Chain Analysis

4. Market Positioning of Key Players, 2021
4.1. Company market share of key players, 2021
4.2. Top 6 Players
4.3. Top 3 Players
4.4. Major Strategies Adopted by Key Players

5. COVID 19 Impact Analysis
5.1. Global Naloxone Market Pre Vs Post COVID 19, 2019 – 2028
5.2. Impact on Import & Export
5.3. Impact on Demand & Supply

6. North America
6.1. North America Naloxone Market, by Country, 2016-2028(US$ Bn)
6.1.1. U.S.
6.1.2. Canada
6.1.3. Mexico
6.2. North America Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
6.2.1. Overview
6.2.2. Injectables
6.2.3. Nasal
6.2.4. Oral
6.2.5. Others
6.3. North America Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
6.3.1. Overview
6.3.2. Hospital Pharmacies
6.3.3. Retail Pharmacies
6.3.4. Others
6.4. North America Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
6.4.1. Overview
6.4.2. Solvent-Extracted
6.4.3. Cold-Pressed
6.5. North America Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
6.5.1. Overview
6.5.2. Direct Sales
6.5.3. Hypermarkets/Supermarkets
6.5.4. Convenience Stores
6.5.5. Specialty Retail Stores
6.5.6. Online Retailers
6.5.7. Others

7. Europe
7.1. Europe Naloxone Market, by Country, 2016-2028(US$ Bn)
7.1.1. UK
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Ukraine
7.1.7. Spain
7.1.8. Belgium
7.1.9. Netherland
7.1.10. Austria
7.1.11. Sweden
7.1.12. Poland
7.1.13. Denmark
7.1.14. Switzerland
7.1.15. Rest of Europe
7.2. Europe Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Injectables
7.2.3. Nasal
7.2.4. Oral
7.2.5. Others
7.3. Europe Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Hospital Pharmacies
7.3.3. Retail Pharmacies
7.3.4. Others
7.4. Europe Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Solvent-Extracted
7.4.3. Cold-Pressed
7.5. Europe Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
7.5.1. Overview
7.5.2. Direct Sales
7.5.3. Hypermarkets/Supermarkets
7.5.4. Convenience Stores
7.5.5. Specialty Retail Stores
7.5.6. Online Retailers
7.5.7. Others

8. Asia Pacific
8.1. Asia Pacific Naloxone Market, by Country, 2016-2028(US$ Bn)
8.1.1. China
8.1.2. Japan
8.1.3. South Korea
8.1.4. India
8.1.5. Australia
8.1.6. New Zealand
8.1.7. Taiwan
8.1.8. Indonesia
8.1.9. Malaysia
8.1.10. Philippine
8.1.11. Rest of Asia Pacific
8.2. Asia Pacific Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. Injectables
8.2.3. Nasal
8.2.4. Oral
8.3. Asia Pacific Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. Hospital Pharmacies
8.3.3. Retail Pharmacies
8.3.4. Others
8.4. Asia Pacific Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. Solvent-Extracted
8.4.3. Cold-Pressed
8.5. Asia Pacific Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
8.5.1. Overview
8.5.2. Direct Sales
8.5.3. Hypermarkets/Supermarkets
8.5.4. Convenience Stores
8.5.5. Specialty Retail Stores
8.5.6. Online Retailers
8.5.7. Others

9. Latin America
9.1. Latin America Naloxone Market, by Country, 2016-2028(US$ Bn)
9.1.1. Brazil
9.1.2. Argentina
9.1.3. Peru
9.1.4. Chile
9.1.5. Colombia
9.1.6. Rest of Latin America
9.2. Latin America Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. Injectables
9.2.3. Nasal
9.2.4. Oral
9.2.5. Others
9.3. Latin America Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. Hospital Pharmacies
9.3.3. Retail Pharmacies
9.3.4. Others
9.4. Latin America Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. Solvent-Extracted
9.4.3. Cold-Pressed
9.5. Latin America Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
9.5.1. Overview
9.5.2. Direct Sales
9.5.3. Hypermarkets/Supermarkets
9.5.4. Convenience Stores
9.5.5. Specialty Retail Stores
9.5.6. Online Retailers
9.5.7. Others

10. Middle East
10.1. Middle East Naloxone Market, by Country, 2016-2028(US$ Bn)
10.1.1. UAE
10.1.2. KSA
10.1.3. Israel
10.1.4. Turkey
10.1.5. Iran
10.1.6. Rest of Middle East
10.2. Middle East Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. Injectables
10.2.3. Nasal
10.2.4. Oral
10.2.5. Others
10.3. Middle East Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. Hospital Pharmacies
10.3.3. Retail Pharmacies
10.3.4. Others
10.4. Middle East Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. Solvent-Extracted
10.4.3. Cold-Pressed
10.5. Middle East Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
10.5.1. Overview
10.5.2. Direct Sales
10.5.3. Hypermarkets/Supermarkets
10.5.4. Convenience Stores
10.5.5. Specialty Retail Stores
10.5.6. Online Retailers
10.5.7. Others

11. Africa
11.1. Africa Naloxone Market, by Country, 2016-2028(US$ Bn)
11.1.1. South Africa
11.1.2. Egypt
11.1.3. Nigeria
11.1.4. Rest of Africa
11.2. Africa Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. Injectables
11.2.3. Nasal
11.2.4. Oral
11.2.5. Others
11.3. Africa Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. Hospital Pharmacies
11.3.3. Retail Pharmacies
11.3.4. Others
11.4. Africa Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. Solvent-Extracted
11.4.3. Cold-Pressed
11.5. Africa Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
11.5.1. Overview
11.5.2. Direct Sales
11.5.3. Hypermarkets/Supermarkets
11.5.4. Convenience Stores
11.5.5. Specialty Retail Stores
11.5.6. Online Retailers
11.5.7. Others

12. Global
12.1. Global Naloxone Market, by Route of Administration, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. Injectables
12.1.3. Nasal
12.1.4. Oral
12.1.5. Others
12.2. Global Naloxone Market, by Distribution Channel, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. Hospital Pharmacies
12.2.3. Retail Pharmacies
12.2.4. Others
12.3. Global Naloxone Market, by Extraction Process, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. Solvent-Extracted
12.3.3. Cold-Pressed
12.4. Global Naloxone Market, by Sales Channel, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. Direct Sales
12.4.3. Hypermarkets/Supermarkets
12.4.4. Convenience Stores
12.4.5. Specialty Retail Stores
12.4.6. Online Retailers
12.4.7. Others

13. Company Profiles
13.1. SG Pharma Pvt. Ltd.
13.2. ADAPT Pharma, Inc.
13.3. Kaleo, Inc.
13.4. Pfizer Inc.
13.5. Amphastar Pharmaceuticals, Inc.
13.6. Sandoz
13.7. Troikaa Pharmaceuticals Ltd.
13.8. Samarth Life Sciences Pvt. Ltd.
13.9. Somerset Therapeutics LLC
13.10. Others

List of Figures

FIG. 1 Global Naloxone Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Naloxone Market Segmentation
FIG. 4 Global Naloxone Market, by Route of Administration, 2019 (US$ Bn)
FIG. 5 Global Naloxone Market, by Distribution Channel, 2021 (US$ Bn)
FIG. 6 Global Naloxone Market, by Geography, 2021 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Geography, 2021
FIG. 8 Global Market Positioning of Key Naloxone Market Manufacturers, 2019
FIG. 9 Global Naloxone Market Value Contribution, By Route of Administration, 2021 & 2028 (Value %)
FIG. 10 Global Naloxone Market, by Injectables, Value, 2016-2028 (US$ Bn)
FIG. 11 Global Naloxone Market, by Nasal, Value, 2016-2028 (US$ Bn)
FIG. 12 Global Naloxone Market, by Oral, Value, 2016-2028 (US$ Bn)
FIG. 13 Global Naloxone Market Value Contribution, By Distribution Channel, 2021 & 2028 (Value %)
FIG. 14 Global Naloxone Market, by Hospital Pharmacies, Value, 2016-2028 (US$ Bn)
FIG. 15 Global Naloxone Market, by Retail Pharmacies, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Naloxone Market Value Contribution, By Extraction Process, 2021 & 2028 (Value %)
FIG. 17 Global Naloxone Market, by Solvent-Extracted, 2016-2028 (US$ Bn)
FIG. 18 Global Naloxone Market, by Cold-Pressed, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Naloxone Market Value Contribution, By Sales Channel, 2021 & 2028 (Value %)
FIG. 20 Global Naloxone Market, by Direct Sales, 2016-2028 (US$ Bn)
FIG. 21 Global Naloxone Market, by Hypermarkets/Supermarkets, 2016-2028 (US$ Bn)
FIG. 22 Global Naloxone Market, by Convenience Stores, 2016-2028 (US$ Bn)
FIG. 23 Global Naloxone Market, by Specialty Retail Stores, 2016-2028 (US$ Bn)
FIG. 24 Global Naloxone Market, by Online Retailers, 2016-2028 (US$ Bn)
FIG. 25 Global Naloxone Market Value Contribution, By Sales Channel, 2021 & 2028 (Value %)
FIG. 26 Global Naloxone Market, by Online, 2016-2028 (US$ Bn)
FIG. 27 Global Naloxone Market, by Direct Sales, 2016-2028 (US$ Bn)
FIG. 28 Global Naloxone Market, by Pharmacies/Drug Stores, 2016-2028 (US$ Bn)
FIG. 29 Global Naloxone Market, by Other offline channels, 2016-2028 (US$ Bn)
FIG. 30 U.S. Naloxone Market, 2016-2028 (US$ Bn)
FIG. 31 Rest of North America Naloxone Market, 2016-2028 (US$ Bn)
FIG. 32 U.K. Naloxone Market, 2016-2028 (US$ Bn)
FIG. 33 Germany Naloxone Market, 2016-2028 (US$ Bn)
FIG. 34 France Naloxone Market, 2016-2028 (US$ Bn)
FIG. 35 Italy Naloxone Market, 2016-2028 (US$ Bn)
FIG. 36 Spain Naloxone Market, 2016-2028 (US$ Bn)
FIG. 37 Russia Naloxone Market, 2016-2028 (US$ Bn)
FIG. 38 BENELUX Naloxone Market, 2016-2028 (US$ Bn)
FIG. 39 Poland Naloxone Market, 2016-2028 (US$ Bn)
FIG. 40 Austria Naloxone Market, 2016-2028 (US$ Bn)
FIG. 41 Rest of Europe Naloxone Market, 2016-2028 (US$ Bn)
FIG. 42 Japan Naloxone Market, 2016-2028 (US$ Bn)
FIG. 43 China Naloxone Market, 2016-2028 (US$ Bn)
FIG. 44 India Naloxone Market, 2016-2028 (US$ Bn)
FIG. 45 South Korea Naloxone Market, 2016-2028 (US$ Bn)
FIG. 46 Australia Naloxone Market, 2016-2028 (US$ Bn)
FIG. 47 Southeast Asia Naloxone Market, 2016-2028 (US$ Bn)
FIG. 48 Rest of Asia Pacific Naloxone Market, 2016-2028 (US$ Bn)
FIG. 49 Middle East & Africa Naloxone Market, 2016-2028 (US$ Bn)
FIG. 50 South Africa Naloxone Market, 2016-2028 (US$ Bn)
FIG. 51 Nigeria Naloxone Market, 2016-2028 (US$ Bn)
FIG. 52 Egypt Naloxone Market, 2016-2028 (US$ Bn)
FIG. 53 GCC Naloxone Market, 2016-2028 (US$ Bn)
FIG. 54 Israel Naloxone Market, 2016-2028 (US$ Bn)
FIG. 55 Latin America Naloxone Market, 2016-2028 (US$ Bn)
FIG. 56 Mechanicalzil Naloxone Market, 2016-2028 (US$ Bn)
FIG. 57 Argentina Naloxone Market, 2016-2028 (US$ Bn)
FIG. 58 Colombia Naloxone Market, 2016-2028 (US$ Bn)
FIG. 59 Peru Naloxone Market, 2016-2028 (US$ Bn)
FIG. 60 Chile Naloxone Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Naloxone Market
TABLE 2 Global Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 3 Global Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 4 Global Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 5 Global Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 6 Global Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 7 Global Naloxone Market, by Geography, 2016-2028 (US$ Bn)
TABLE 8 North America Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 9 North America Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 10 North America Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 11 North America Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 12 North America Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 13 North America Naloxone Market, by Country, 2016-2028 (US$ Bn)
TABLE 14 Europe Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 15 Europe Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 16 Europe Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 17 Europe Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 18 Europe Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 19 Europe Naloxone Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 20 Asia Pacific Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 21 Asia Pacific Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 22 Asia Pacific Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 23 Asia Pacific Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 24 Asia Pacific Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 25 Asia Pacific Naloxone Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 26 Latin America Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 27 Latin America Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 28 Latin America Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 29 Latin America Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 30 Latin America Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 31 Latin America Naloxone Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 32 Middle East Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 33 Middle East Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 34 Middle East Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 35 Middle East Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 36 Middle East Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 37 Middle East Naloxone Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 38 Africa Naloxone Market, by Route of Administration, 2016-2028 (US$ Bn)
TABLE 39 Africa Naloxone Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 40 Africa Naloxone Market, by Extraction Process, 2016-2028 (US$ Bn)
TABLE 41 Africa Naloxone Market, by Consumer, 2016-2028 (US$ Bn)
TABLE 42 Africa Naloxone Market, by Sales Channel, 2016-2028 (US$ Bn)
TABLE 43 Africa Naloxone Market, by Country/Region, 2016-2028 (US$ Bn)

Frequently asked questions

Which is the leading market for Naloxone?

North America accounted for the highest share in the global Naloxone market in terms of value as well as volume.

What are the key drivers for the growth of the Naloxone market?

Globally, the use of opioids for chronic pain management is increasing, and as a result, non-medical opioid use is rising are the major factors driving the market growth.

Which is the major segment in Naloxone Market by Route Of Administration?

Nasal Naloxone had a major share in 2021 with more than 40% of the market revenue share.

Which is the major segment in Naloxone Market by Distribution Channel?

Hospital Pharmacies had a major share in the global market in 2021 and is projected to continue its growth over the forecast period.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –